Action steps for African Business Schools
2011-05-24 13:56:36 UTC
Case Study: GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (B): THE SETTLEMENT
Title
GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (B): THE SETTLEMENT
Author
Yaziji, M ; Lindblom, A
Pages
2
Product Type
Reference #
IMD-3-1497
Teaching Note
Institute
Setting
Year
Keywords
Non-government organisations (NGO's) ; Non-market competition ; Ethics ; Pharmaceutical ; AIDS ; Patents
Summary/
Abstract
Abstract
This is the second of a four-case series (IMD-3-1496 to IMD-3-1499). The (B) part of the series focuses on the outcome of the lawsuit against the South African government. But the demands from the non-government organisations (NGO's) keep on coming and Garnier, the CEO of GlaxoSmithKline (GSK), is faced with some tough decisions to make. Should he allow licensing? How should he deal with parallel importation?
The Impact of AABS Video
"The impact of AABS Video" was filmed at the Gordon Institute of Business Science, Johannesburg and at the University of Cape Town Graduate School of Business, Cape Town during the AABS Members Meeting and Conference 2011.
- Find out more about becoming an AABS Member or an AABS Pipeline School
- Interested in consulting to our member schools or teaching on our AABS programmes? contact us.
AABS is proud to announce our new project: African Agribusines Network (AAgri.net). Visit the website.
Reports on the AABS Members Meeting 2011 and Responsible Management in Africa Conference 2011
